Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Women's Health

Women's Health

                        


                        Women's Health Topics
          Women's Health Research
          OWH Education and Training
          OWH News and Updates
          OWH Resources for Stakeholders
          About OWH Home
          For Consumers
          Women's Health
          Scientific Conference: Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender - 09/27/2018Women's Health Symposium
    Event Title
              Scientific Conference: Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender


                  September 27 - 28, 2018

  

    
  Share
    Post
    Linkedin

    Email
    PrintOn This Page
      Meeting Information
                Event MaterialsDate:
          
  


     
                                                       
       

September 27 - 28, 2018   

 
 
        
                                      Time: 
                                      
8:00 AM
    - 4:00 PM
ET
                
  Organized By: 
      Organizer
          Food and Drug Administration

 





Sex differences may influence susceptibility to substance abuse, which could have implications for optimal prevention and treatment. Gender influences also impact public health from an environmental perspective. To identify and treat women most at risk, researchers, educators, and clinicians must be able to recognize and consider both sex and gender differences.

The U.S. Food and Drug Administration’s Office of Women’s Health, in collaboration with the Center for Drug Evaluation and Research and the Center for Tobacco Products, will be hosting a 2-day public meeting, “Scientific Conference: Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender,” to address this important issue. The conference will include presentations by experts in the field of opioid and tobacco research, professional education, and clinical care on the biological (sex) and sociological (gender) influences on use, misuse, and recovery.

**Webcast Recording Day 1- Sept 27 2018**

**Webcast Recording Day 2- Sept 28 2018**

Keynote Speakers

**Day 1**

Commissioner Scott Gottlieb, MD

*Scott Gottlieb, M.D.**Commissioner of Food and Drugs*

**Day 2**

RADM Sylvia Trent-Adams, PhD, RN, FAAN
*RADM Sylvia Trent-Adams, Ph.D, R.N., F.A.A.N.
Deputy U.S. Surgeon General*

**When**: Thursday, September 27, 2018, and Friday, September 28, 2018, from 8:30 a.m. - 4:00 p.m.

Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender

Conference Report: Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender (758.78 KB)
	Final Program - Scientific Conference: Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender
	Executive Summary - Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender
	Backgrounder: Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and GenderExecutive Steering Committee (ESC)

Committee Member
			TitleAmi Bahde, MPH
			Program Analyst, FDA CTPTerri Cornelison, MD, PhD, FACOG
			Assistant Director for the Health of Women, FDA CDRHCarolyn Dresler, MD, MPA
			Associate Director For Medical and Health Sciences, FDA CTPMarjorie Jenkins, MD, MEdHP, FACP
			Director of Medical Initiatives and Scientific Engagement, FDA OWHTamra Meyer, PhD, MPH
			Lead Epidemiologist, FDA CDER OSEPamela Scott, PhD
			Deputy Director, Office of Women's Health; Director of Research and Development, FDA OWHJessica Tytel, MPH
			Senior Advisor, HHS OWHRita Valentino, PhD
			Director, Division of Neuroscience and Behavior, NIH NIDACora Lee Wetherington, PhD
			Women & Sex/Gender Differences Research Coordinator, NIH NIDACelia Winchell, MD
			Medical Officer Team Leader (addiction, drugs), FDA CDER DAAAP



Scientific Planning Committee (SPC)

Committee Member
			TitleLori Bastian, MD, MPH
			Professor of Internal Medicine (General Medicine);
			Section Chief of General Internal Medicine, VA Connecticut Healthcare System;
			Director, Pain Research, Informatics, Multimorbidities, and Education (PRIME) CenterJill Becker, PhD
			Research Professor, Department of Psychiatry, Molecular and
			Behavioral Neuroscience Institute, University of MichiganMichele Bloch, MD, PhD
			Chief, Tobacco Control Research Branch, Behavioral Research Program, NIH NCIKathleen Brady, MD, PhD
			Distinguished University Professor, Associate Provost, Clinical and Translational Science;
			Director, South Carolina Clinical and Translational Research Institute (SCTR),
			Medical University of South CarolinaTerri Cornelison, MD, PhD, FACOG
			Assistant Director for the Health of Women, FDA CDRHCarolyn Dresler, MD, MPA
			Associate Director for Medical and Health Sciences, FDA CTPPhyllis E. Greenberger, MSW
			Senior VP of Science and Health Policy, Healthy WomenGioia Guerrieri, DO
			Medical Officer, CDER DAAAPAmber Jessup, PhD
			Senior Economist, HHS ASPEMarjorie Jenkins, MD, MEdHP, FACP
			Director of Medical Initiatives and Scientific Engagement, FDA OWHHendrée Jones, PhD
			Professor, Department of Obstetrics and Gynecology;
			Executive Director of UNC Horizons, University of North Carolina Chapel Hill School of MedicineKarin Mack, PhD
			Science Officer, CDCSherry McKee, PhD
			Professor of Psychiatry; Director, Yale Behavioral Pharmacology Laboratory;
			Clinical Director, Forensic Drug Diversion Clinic;
			Director, Yale-SCOR to Develop Gender-Sensitive Therapeutics for Addiction
			Yale University School of MedicineChad D. Morris, PhD
			Associate Professor, Department of Psychiatry,
			Director of the Behavioral Health and Wellness Program,
			Co-Director of the Wellness Leadership Institute, University of ColoradoJudith (Jodi) Prochaska, PhD, MPH
			Associate Professor, Department of Medicine, Stanford UniversityJane Segebrecht, MPH
			Public Health Analyst, Team Lead, HHS HRSASayeedha Uddin, MD, MPH
			Senior Public Health Analyst, HHS OWHCora Lee Wetherington, PhD
			Women & Sex/Gender Differences Research Coordinator, NIH NIDAJessica White, MPP
			Social Science Analyst and CDC Team Lead, Division of Science Policy, HHS ASPEScott Winiecki, MD
			Lead Medical Officer, FDA CDER PASE







Event Materials

  Title
            File Type/SizeExecutive Summary - Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender
              pdf               (1.76 MB)

                                                                                  Content current as of:
      07/25/2019More Meetings,
      Conferences, and
      Workshops
        
        Women's Health

          
                        


                        Women's Health Topics
          Women's Health Research
          Education and Training
          News and Updates
          Resources for Stakeholders
          About OWH
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop